Brief: Avalo Therapeutics Enters Milestone Buyout Option Agreement On April 26 - SEC Filing
28/04/2026 12:13
April 28 (Reuters) - SEC Filing: AVALO THERAPEUTICS INC - ENTERS MILESTONE BUYOUT OPTION AGREEMENT ON APRIL 26, 2026 - SEC FILING AVALO THERAPEUTICS INC - TO PAY $2.25 MILLION TO SECURITYHOLDERS' REPRESENTATIVE WITHIN FIVE BUSINESS DAYS OF APRIL 26, 2026 - SEC FILING Source text: [ID:n0001534120-26-000026] Further company coverage: AVTX.O ((Reuters.Briefs@thomsonreuters.com;))